Skip to main content

IDEX Biometrics ASA: Listing of Warrants – 12 Dec 2024

Written by Customer Service on . Posted in Public Companies.

Reference is made to the private placement (the “Private Placement”) completed in IDEX Biometrics ASA (the “Company”) on 17 September 2024, and to the subsequent offering completed in the Company on 29 November 2024 (the “Subsequent Offering”). The subscribers in the Private Placement and the Subsequent Offering were allocated two warrants, Warrants A and Warrants B (collectively, the “Warrants”), respectively, issued by the Company for every two Offer Shares allocated to, and paid by, them in the Private Placement and the Subsequent Offering. As previously announced by the Company, the Company shall use reasonable efforts to seek to ensure that the Warrants are admitted to trading on Euronext Oslo Børs.

The Warrants will be admitted to trading on Euronext Oslo Børs on 12 December 2024.

The Warrants have already been allocated to the subscribers of the Private Placement and the Subsequent Offering and will be tradable. Warrants A will be tradable from 12 December 2024 until 7 March 2025. Warrants B will be tradable from 12 December 2024 until 7 April 2025.

Warrants A may only be exercised within the first 14 days following the Company’s announcement of its Q4 2024 financial report (announcement expected on 27 February 2025, and the expected exercise period is between 28 February 2025 and 13 March 2025), and all Warrants A not exercised within such period will lapse without compensation to the holder. Warrants B may only be exercised from 31 March 2025 to 11 April 2025, and all Warrants B not exercised within such period will lapse without compensation to the holder.

Each Warrant will give the holder a right to subscribe for one new share in the Company at a subscription price of NOK 0.15. The Warrants are expected to have an economic value.

For more information relating to the Warrants, please refer to the Prospectus approved and published by the Company on 13 November 2024.

For further information contact:
Marianne Bøe, Head of Investor Relations
Kristian Flaten, CFO
E-mail: ir@idexbiometrics.com
Tel: +47 6783 9119

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com)

About this notice:
This notice was issued by Marianne Bøe, Head of Investor Relations, on 12 December 2024 at 07:30 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.